Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 3:48 AM
Ignite Modification Date:
2025-12-25 @ 3:48 AM
NCT ID:
NCT00152802
Eligibility Criteria:
Inclusion Criteria:
Male or female outpatients who fulfill the following criteria will be eligible for the study:
* Liver transplant recipients greater than 3 months post-transplant
* No prior pneumococcal vaccination within the last 5 years
* Stable allograft function as evidenced by a alanine aminotransferase \<10 times the upper limit of normal (mmol/L) that is not worsening
* Able to provide written informed consent and comply with study protocol
* Age \> 16
Exclusion Criteria:
* Unable to provide informed consent or comply with protocol
* Prior pneumococcal vaccination within 5 years of enrolment
* Splenectomy
* Admitted to hospital for acute illness
* Febrile illness in the past 2 weeks
* Intravenous Immunoglobulin in the last 6 months
* Current episode of allograft rejection
* Currently on full-dose anticoagulation as a contraindication to intramuscular injection
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
16 Years
Study:
NCT00152802
Study Brief:
Protocol Section:
NCT00152802